Ambrx Biopharma American Volatility

AMAMDelisted Stock  USD 15.73  0.71  4.73%   
We have found twenty-nine technical indicators for Ambrx Biopharma American, which you can use to evaluate the volatility of the firm. Please confirm Ambrx Biopharma's risk adjusted performance of 0.0967, and Mean Deviation of 3.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Ambrx Biopharma's volatility include:
720 Days Market Risk
Chance Of Distress
720 Days Economic Sensitivity
Ambrx Biopharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Ambrx daily returns, and it is calculated using variance and standard deviation. We also use Ambrx's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Ambrx Biopharma volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Ambrx Biopharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Ambrx Biopharma at lower prices. For example, an investor can purchase Ambrx stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Ambrx Biopharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Ambrx Stock

  0.82SSNLF Samsung ElectronicsPairCorr
  0.82PTAIF PT Astra InternationalPairCorr

Moving against Ambrx Stock

  0.77MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.72BKRKF PT Bank RakyatPairCorr
  0.69BKRKY Bank RakyatPairCorr
  0.68PPERF Bank Mandiri PerseroPairCorr
  0.65TLK Telkom Indonesia TbkPairCorr
  0.65PPERY Bank Mandiri PerseroPairCorr
  0.56BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.49PG Procter Gamble Sell-off TrendPairCorr

Ambrx Biopharma Market Sensitivity And Downside Risk

Ambrx Biopharma's beta coefficient measures the volatility of Ambrx stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Ambrx stock's returns against your selected market. In other words, Ambrx Biopharma's beta of 1.41 provides an investor with an approximation of how much risk Ambrx Biopharma stock can potentially add to one of your existing portfolios. Ambrx Biopharma American exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ambrx Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ambrx Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Ambrx Biopharma American Demand Trend
Check current 90 days Ambrx Biopharma correlation with market (Dow Jones Industrial)

Ambrx Beta

    
  1.41  
Ambrx standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  0.0  
It is essential to understand the difference between upside risk (as represented by Ambrx Biopharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Ambrx Biopharma's daily returns or price. Since the actual investment returns on holding a position in ambrx stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Ambrx Biopharma.

Ambrx Biopharma American Stock Volatility Analysis

Volatility refers to the frequency at which Ambrx Biopharma delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Ambrx Biopharma's price changes. Investors will then calculate the volatility of Ambrx Biopharma's stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Ambrx Biopharma's volatility:

Historical Volatility

This type of delisted stock volatility measures Ambrx Biopharma's fluctuations based on previous trends. It's commonly used to predict Ambrx Biopharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Ambrx Biopharma's current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Ambrx Biopharma's to be redeemed at a future date.
Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Ambrx Biopharma Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.4071 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ambrx Biopharma will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ambrx Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ambrx Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ambrx delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Ambrx Biopharma American has an alpha of 0.407, implying that it can generate a 0.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Ambrx Biopharma's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how ambrx stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Ambrx Biopharma Price Volatility?

Several factors can influence a delisted stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Ambrx Biopharma Stock Return Volatility

Ambrx Biopharma historical daily return volatility represents how much of Ambrx Biopharma delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7444% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Ambrx Biopharma Volatility

Volatility is a rate at which the price of Ambrx Biopharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Ambrx Biopharma may increase or decrease. In other words, similar to Ambrx's beta indicator, it measures the risk of Ambrx Biopharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Ambrx Biopharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. The company was incorporated in 2003 and is headquartered in La Jolla, California. Ambrx Biopharma operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 81 people.
Ambrx Biopharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Ambrx Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Ambrx Biopharma's price varies over time.

3 ways to utilize Ambrx Biopharma's volatility to invest better

Higher Ambrx Biopharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Ambrx Biopharma American stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Ambrx Biopharma American stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Ambrx Biopharma American investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Ambrx Biopharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Ambrx Biopharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Ambrx Biopharma Investment Opportunity

Dow Jones Industrial has a standard deviation of returns of 0.74 and is 9.223372036854776E16 times more volatile than Ambrx Biopharma American. Compared to the overall equity markets, volatility of historical daily returns of Ambrx Biopharma American is lower than 0 percent of all global equities and portfolios over the last 90 days. You can use Ambrx Biopharma American to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Ambrx Biopharma to be traded at $19.66 in 90 days.

Modest diversification

The correlation between Ambrx Biopharma American and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ambrx Biopharma American and DJI in the same portfolio, assuming nothing else is changed.

Ambrx Biopharma Additional Risk Indicators

The analysis of Ambrx Biopharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Ambrx Biopharma's investment and either accepting that risk or mitigating it. Along with some common measures of Ambrx Biopharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Ambrx Biopharma Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Ambrx Biopharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Ambrx Biopharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Ambrx Biopharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Ambrx Biopharma American.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Ambrx Stock

If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance